1/148
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Med for muscle issue
muscle relaxant
psychosocial meds
SNRI, tricyclic antidepressant
meds for neuropathic pain
gabapetenoid
gabapentinoid can’t be taken
prn
pregabalin has lower dosage than
gabapentin
nociplastic pain meds
SNRI, tricyclic antidepressant (also maybe gabapentinoids, acetaminophen, and NSAIDS?)
nociceptive pain meds
topical analgesic, NSAIDs, opioid, channel blockers
time to fall asleep
sleep latency
ideal sleep latency
0-30 min
desired sleep efficiency
>85%
graded exposure
progression of engagement along fear hierarchy, psychological
graded activity
progressive increase
isometrics are used early in rehab to produce analgesia with
certain tendon pains
aerobic exercise is appropriate for
all pain mechanisms
exercise impact on central inhibition
increases central inhibition (opioidergic and serotonergic)
exercise impact on central facilitation
reduces central facilitation (NMDA receptors not active)
exercise impacts
systemic inflammation and the immune system
sedentary lifestyle and chronic pain have a
bidirectional relationship
proposed mechanisms of neurodynamics
reduce immune response/inflammation from n. injury
reduce local perineurial and intramural edema
reduce hyperalgesia (mechanical and thermal(
reduce neural adhesions
neurodynamics could have
systemic effects
types of manual therapy
soft tissue based
nerve biased
joint based
mobs (low velocity)
manipulations (high velocity)
velocity of mobs
low
velocity of manipulations
high
STAR shoulder classification
screen flags, assign pathoanatomical diagnosis, assign rehab classification
LBP you should
screen for red flags, clarify symptom irritability, classify into treatment classification (manipulation, stabilization, special exercises, traction)
with low irritability, you can push
into resistance
with medium irritability, use
caution against high force mobs
with high irritability, push not
into tissue resistance
nerve treatment dosage
less is more, touch into symptoms, keep it low to avoid flareups
tendon/muscle exercise should not cause pain to be
≥4/10 before or after exercise
exercise for bone should have
no pain before/after
for nociplastic pain, address
neuroplasticity
top-down drivers
bad childhood experiences
depression
anxiety
stress
fear avoidance beliefs
bottom-up/peripheral drivers
tissue injury
muscle weakness
medical co-morbidities
Stages of GMI
L/R discrimination, explicit motor imagery, mirror therapy
SINSS model
Severity, irritability, nature, stage, stability
“why did things that were fine now cause pain?”
envelope of function (preventing boom/bust)
“will it ever go away?”
pain vs function
“why am I still in pain?”
alarm system
Cellular processes that can contribute to central sensitization
increase of membrane excitability, synaptic facilitation, disinhibition
nervous system changes resulting from central sensitization
development or increase in spontaneous activity, reduction in threshold for activation by peripheral stimuli, enlargement of receptive fields
enlargement of receptive fields refers to
conversion of nociceptive-specific neurons to wide dynamic neurons that now respond to both innocuous and noxious stimuli
sensitization can occur at
any point along the neural axis
maladaptive neuroplasticity
subcortical and cortical reorganization
central sensitization changes at
secondary nociceptive neuron
peripheral sensitization changes at
primary nociceptive neuron
peripheral sensitization cell body
in DRG
central sensitization cell body
in spinal cord
CSI is a… outcome measure
nociplastic
CSI>40 indicates
likely central sensitization
OA can cause
chronic pain, brain changes
ACL-R can cause
maladaptive neuroplasticity
chronic LBP can cause
tactile dysfunction, body image distortion
tendinopathy can cause
sensitization
MSK dx can cause
altered pain processing, impairments to CNS
central sensitization in neuropathic pain
neuroinflammation and glial cell activity, increased responsiveness of dorsal horn neurons (wind-up or temporal summation) likely cause and/or reduction in descending inhibition/cortical reorganization, unregulated NK1-R, decreased threshold for substance P to activate SC neuron, pro-inflammatory cytokines released from microglia
peripheral sensitization in neuropathic pain
up regulation of receptor channels at 1° afferent nociceptor (a delta), reduced threshold to responsiveness
c fiber cell bodies live in
DRG
NK1-R is a receptor for
substance P
possible causes of neuropathic pain
ectopic impulse generation at site of nerve injury or DRG (phantom limb pain), compression of nerve (vascular compromise), up regulation of TRPV1 and/or acid sensing channels @ 1° sensory afferent (peripheral sensitization)
neuropathic pain possible lesion sites/types
genetic disease affecting receptors and/or ion channels of peripheral nociceptive neuron, damage to peripheral nociceptive axon or myelin, SC lesion affecting spinothalamic tract, thalamic lesion
nerves need
blood, movement, and space
neuropathic pain is caused by
lesion or disease of somatosensory system
cerebellar lesions can/cannot cause neuropathic pain
CANNOT
somatosensory lesion can be in the
PNS or CNS
pain DETECT <12 indicates
unlikely neuropathic component to pain
pain DETECT ≥19 indicates
likely neuropathic component
S_LANSS <12 indicates
unlikely neuropathic component
S-LANSS ≥12 indicates
likely neuropathic component
spinothalamic tract, aka
anterolateral system
MCID on NPRS
2 points
NPRS
numeric pain rating scale
VAS MCID
20mm
nociceptive pain outcomes
VAS, NPRS
4 D’s of nociplastic pain
disproportionate pain, disproportionate aggravating/easing factors, diffuse pain/palpation tenderness, distress
3 S’s of neuropathic pain
subjective hx of nerve pathology, sensory deficits in dermatomal pattern, stretching nerve provokes
4 P’s of nociceptive pain
proportional, provokable, periodic, predictable
exercise therapy for neuropathic and nociplastic pain should take this approach
cognitive behavioral (including time-contingent approach)
exercise therapy for nociceptive pain should take this approach
pain contingent approach
pt ed for nociceptive
explain presumed source of nociception
pt ed for neuropathic
explain lesion or disease of nervous system and central sensitization
nociplastic pt ed
explain central sensitization
neuropathic is limited to
neuroanatomically plausible distributions
nociplastic outcome measures
CSI
neuropathic outcome measures
S-LANSS, painDETECT
nociceptive outcome measures
NPRS, VAS
CPM
ability of descending pain inhibitory mechanisms (central) to effectively inhibit pain following a painful stimulus (e.g. increased PPT after cold water bath)
wind-up
progressively increasing activity in dorsal horn cells following repetitive activation of primary afferent c fibers
temporal summation
increased pain response to repetitive noxious stimuli to C/A delta fibers at <3Hz, central sensitization results in steeper ramp up in responsiveness
neurogenic inflammation
nociceptors acting on adjacent tissues by releasing inflammatory mediators (can vasodilate and increase permeability)
process proposed to contribute to 2° hyperalgesia
heterosynaptic facilitation
heterosynaptic faciliation
interneuronal facilitation of adjacent spinal projection pathways, may explain expansion of pain beyond area of insult (nosy neighbors)
process proposed to contribute to primary hyperalgesia
homosynpatic facilitation
homosynaptic facilitation
repeated peripheral input sensitizes dorsal horn projection neurons in nociceptive pathway
central sensitization
increased responsiveness of dorsal horn (spinal cord) neurons (wind up or temporal summation) and/or reduction in descending inhibition
central sensitization has increase in activity of
microglia and astrocytes at dorsal horn
peripheral sensitization
reduced threshold of peripheral nociceptive neurons (A delta, C fibers) and/or increased responsiveness
TRP
transient receptor potential
in peripheral sensitization, channels
TRP and sodium/calcium channels may have increased expression and/or responsiveness, this makes it easier to activate neurons (which increase peripheral nociceptive input to nervous system)
C fibers
slow, small diameter, unmyelinated, nociception, cell body in DRG, associated with dull, subacute, longer lasting pain, poorly localizezd